192 related articles for article (PubMed ID: 13680026)
21. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
[TBL] [Abstract][Full Text] [Related]
22. First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Burger IA; Zitzmann-Kolbe S; Pruim J; Friebe M; Graham K; Stephens A; Dinkelborg L; Kowal K; Schibli R; Luurtsema G; Maas B; Horn-Tutic M; Haerle SK; Wiegers J; Schaefer NG; Hany TF; von Schulthess GK
J Nucl Med; 2014 Nov; 55(11):1778-85. PubMed ID: 25256060
[TBL] [Abstract][Full Text] [Related]
23. Gliomatosis cerebri, imaging findings of 12 cases.
Desclée P; Rommel D; Hernalsteen D; Godfraind C; de Coene B; Cosnard G
J Neuroradiol; 2010 Jul; 37(3):148-58. PubMed ID: 20334921
[TBL] [Abstract][Full Text] [Related]
24. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
Kaira K; Oriuchi N; Shimizu K; Ishikita T; Higuchi T; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Cancer Sci; 2009 Apr; 100(4):753-8. PubMed ID: 19141127
[TBL] [Abstract][Full Text] [Related]
25. Teaching neuroimages: FDG-PET imaging in primary diffuse leptomeningeal gliomatosis.
Weijenberg A; van Dijk JM; Pruim J; Luijckx GJ
Neurology; 2013 Oct; 81(16):e119-20. PubMed ID: 24127193
[No Abstract] [Full Text] [Related]
26. 18F FDG PET/CT in a child with gliomatosis cerebri.
Sürücü E; Mutafoğlu K; Ince D; Cakmakçı H; Demiral A; Polack BD
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):273-4. PubMed ID: 23122744
[No Abstract] [Full Text] [Related]
27. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent.
Inoue T; Tomiyoshi K; Higuichi T; Ahmed K; Sarwar M; Aoyagi K; Amano S; Alyafei S; Zhang H; Endo K
J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678
[TBL] [Abstract][Full Text] [Related]
28. [Gliomatosis cerebri: report of 3 cases and review of recent literatures].
Arai M; Kashihara K; Kaizaki Y; Taguchi M; Kitamura Y
No To Shinkei; 2003 Oct; 55(10):890-7. PubMed ID: 14635518
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging features of canine gliomatosis cerebri.
Schweizer-Gorgas D; Henke D; Oevermann A; Lang J; Vandevelde M; Steffen F
Vet Radiol Ultrasound; 2018 Mar; 59(2):180-187. PubMed ID: 29110365
[TBL] [Abstract][Full Text] [Related]
30. [A case of gliomatosis cerebri in an elderly woman].
Komeno Y; Ako J; Shimada Y; Namba Y; Matsuse T; Toba K; Ouchi Y
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):540-3. PubMed ID: 11523169
[TBL] [Abstract][Full Text] [Related]
31. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer.
Amano S; Inoue T; Tomiyoshi K; Ando T; Endo K
J Nucl Med; 1998 Aug; 39(8):1424-7. PubMed ID: 9708521
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.
Yang S; Wetzel S; Law M; Zagzag D; Cha S
AJNR Am J Neuroradiol; 2002 Mar; 23(3):350-5. PubMed ID: 11900998
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
34. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
35. MRI features of gliomatosis cerebri in a dog.
Martin-Vaquero P; da Costa RC; Wolk KE; Premanandan C; Oglesbee MJ
Vet Radiol Ultrasound; 2012; 53(2):189-92. PubMed ID: 22413939
[TBL] [Abstract][Full Text] [Related]
36. [Gliomatosis cerebri: a biopsy and autopsy case report].
San Millan B; Kaci R; Polivka M; Robert G; Héran F; Gueguen A; Mokhtari K; Gray F
Ann Pathol; 2010 Feb; 30(1):25-9. PubMed ID: 20223351
[TBL] [Abstract][Full Text] [Related]
37. Gliomatosis cerebri presenting as idiopathic intracranial hypertension in a child.
Zunz E; Ben Sira L; Constantini S; Fattal-Valevski A; Yalon M; Roth J; Cagnano E; Kesler A
J Neuroophthalmol; 2011 Dec; 31(4):339-41. PubMed ID: 21566531
[TBL] [Abstract][Full Text] [Related]
38. Gliomatosis cerebri: report of 3 cases.
Harrison JF; Richard HT; Abel TW; Sosnowski JS; Martino AM
J Neurosurg Pediatr; 2010 Sep; 6(3):291-4. PubMed ID: 20809715
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
[TBL] [Abstract][Full Text] [Related]
40. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
